← European Medicine Shortage Tracker · all medicines

Ambrisentan shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Ambrisentan currently has availability issues reported in 3 European registers: France, Greece, Sweden.

Shortage  ATC C02KX02 · also listed as: ambrisentan · data refreshed 13 September 2026

Key facts

As of 13 September 2026, 3 of the 9 tracked registers list current availability issues for Ambrisentan, covering 5 affected product presentations. The longest-running open report was filed in Sweden on 2025-10-16 and has now been open for about 11 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-18; the earliest is 2026-09-18. Notably, 3 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Greece, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Ambrisentan is coded C02KX02 — a medicine acting on the cardiovascular system — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇫🇷 FranceLimited availability
Ambrisentan-Volibris tous dosages
Cardiologieregister ↗
🇬🇷 GreeceLimited availability
AMBRISENTAN
+ 1 more products
unit-dose Blister PVC/PVdC/ALU)
2026-05-222026-09-18Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά άλλα σκευάσματα των ίδιων
Alternatives: VOLIBRIS F.C.TAB 10MG/TAB BT x 30 σε BLIST Εναλλακτικά άλλα σκευάσματα της ίδιας δραστικής
register ↗
🇸🇪 SwedenShortage
Ambrisentan Sandoz 10 mg Filmdragerad tablett
+ 1 more products
Ambrisentan Sandoz 5 mg Filmdragerad tablett
2025-10-162026-08-28
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2025-10: 22025-11: 02025-12: 02026-01: 02026-02: 02026-03: 02026-04: 02026-05: 12026-06: 02026-07: 12025-102026-07

Full report history (5 register entries)

Every individual register entry for Ambrisentan in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GRAMBRISENTANLimited availability2026-07-312026-09-18Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά άλλα σκευάσματα
🇬🇷 GRunit-dose Blister PVC/PVdC/ALU)Limited availability2026-05-222026-09-01ELPEN AE ΦΑΡΜΑΚΕΥΤΙΚΗ ΒΙΟΜΗΧΑΝΙΑ Καθυστέρηση παράδοσης περιε
🇸🇪 SEAmbrisentan Sandoz 10 mg Filmdragerad tablettShortage2025-10-162026-08-28
🇸🇪 SEAmbrisentan Sandoz 5 mg Filmdragerad tablettShortage2025-10-162026-08-28
🇫🇷 FRAmbrisentan-Volibris tous dosagesLimited availabilityCardiologie

Frequently asked

Is Ambrisentan currently in shortage in Europe?

Yes. As of 13 September 2026, availability issues are reported in: France, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Ambrisentan shortage expected to end?

Agency prognoses on file range from 2026-09-18 to 2026-09-18. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Ambrisentan?

3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Ambrisentan availability data come from?

Directly from the official medicines-agency registers that list Ambrisentan: ANSM (France), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Ambrisentan — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ambrisentan/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Ambrisentan availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/ambrisentan/">Ambrisentan shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Ambrisentan: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 13 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.